Why ADAG? Adagene Inc. Analysis, Price & AI Insights | Whystock
ADAG
$3.82+0.14 (+3.80%)
Market ClosedLast close May 1
Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China.